{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:02:30Z","timestamp":1769551350376,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303264\/2013-6"],"award-info":[{"award-number":["303264\/2013-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12035-019-01817-0","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T06:03:09Z","timestamp":1573797789000},"page":"1347-1360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-1390","authenticated-orcid":false,"given":"Carolina","family":"Gubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Andrejew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar Eduardo Jacintho","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliete","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabricio","family":"Figueiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio","family":"Kapczinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Vieira","family":"da Silva Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria Oliveira","family":"Battastini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"issue":"1","key":"1817_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09540260500080534","volume":"17","author":"FM Mondimore","year":"2005","unstructured":"Mondimore FM (2005) Kraepelin and manic-depressive insanity: an historical perspective. Int Rev Psychiatry 17(1):49\u201352","journal-title":"Int Rev Psychiatry"},{"key":"1817_CR2","doi-asserted-by":"crossref","unstructured":"Kraeplin E Manic-Depressive Insanity and Paranoia. 1921, Edinburgh","DOI":"10.1097\/00005053-192104000-00057"},{"issue":"3","key":"1817_CR3","first-page":"413","volume":"50","author":"V Ralevic","year":"1998","unstructured":"Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50(3):413\u2013492","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1817_CR4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbamem.2012.01.002","volume":"1828","author":"A Baroja-Mazo","year":"2013","unstructured":"Baroja-Mazo A, Barber\u00e0-Cremades M, Pelegr\u00edn P (2013) The participation of plasma membrane hemichannels to purinergic signaling. Biochim Biophys Acta 1828(1):79\u201393","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1817_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/mp.2017.188","volume":"23","author":"A Cheffer","year":"2018","unstructured":"Cheffer A, Castillo ARG, Corr\u00eaa-Velloso J, Gon\u00e7alves MCB, Naaldijk Y, Nascimento IC, Burnstock G, Ulrich H (2018) Purinergic system in psychiatric diseases. Mol Psychiatry 23(1):94\u2013106","journal-title":"Mol Psychiatry"},{"key":"1817_CR6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fphar.2017.00661","volume":"8","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signalling: therapeutic developments. Front Pharmacol 8:661","journal-title":"Front Pharmacol"},{"key":"1817_CR7","doi-asserted-by":"crossref","unstructured":"Bobo WV (2017) The diagnosis and management of bipolar I and II disorders: clinical practice update. Mayo Clin Proc","DOI":"10.1016\/j.mayocp.2017.06.022"},{"issue":"5-6","key":"1817_CR8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1399-5618.2011.00952.x","volume":"13","author":"L Backlund","year":"2011","unstructured":"Backlund L, Nikamo P, Hukic DS, Ek IR, Tr\u00e4skman-Bendz L, Land\u00e9n M, Edman G, Schalling M et al (2011) Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder. Bipolar Disord 13(5-6):500\u2013508","journal-title":"Bipolar Disord"},{"issue":"1","key":"1817_CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12035-014-9031-z","volume":"53","author":"C Gubert","year":"2016","unstructured":"Gubert C et al (2016) Role of P2X7 Receptor in an animal model of mania induced by D-amphetamine. Mol Neurobiol 53(1):611\u2013620","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1817_CR10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","volume":"82","author":"RA North","year":"2002","unstructured":"North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82(4):1013\u20131067","journal-title":"Physiol Rev"},{"key":"1817_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2017_59","volume":"1051","author":"R Sluyter","year":"2017","unstructured":"Sluyter R (2017) The P2X7 Receptor. Adv Exp Med Biol 1051:17\u201353","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1817_CR12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","volume":"15","author":"JS Rao","year":"2010","unstructured":"Rao JS, Harry GJ, Rapoport SI, Kim HW (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15(4):384\u2013392","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1817_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/YCO.0b013e32835aa4b4","volume":"26","author":"L Stertz","year":"2013","unstructured":"Stertz L, Magalh\u00e3es PV, Kapczinski F (2013) Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry 26(1):19\u201326","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"1817_CR14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","volume":"35","author":"M Berk","year":"2011","unstructured":"Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Y\u00fccel M, Gama CS et al (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804\u2013817","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"1817_CR15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/mp.2008.6","volume":"14","author":"A McQuillin","year":"2009","unstructured":"McQuillin A, Bass NJ, Choudhury K, Puri V, Kosmin M, Lawrence J, Curtis D, Gurling HM (2009) Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders. Mol Psychiatry 14(6):614\u2013620","journal-title":"Mol Psychiatry"},{"key":"1817_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2018.11.055","volume":"694","author":"C Gubert","year":"2019","unstructured":"Gubert C, Andrejew R, Jacintho Moritz CE, Dietrich F, Vasconcelos-Moreno MP, Dos Santos BTMQ, Fijtman A, Kauer-Sant'Anna M et al (2019) Bipolar disorder and 1513A>C P2RX7 polymorphism frequency. Neurosci Lett 694:143\u2013147","journal-title":"Neurosci Lett"},{"issue":"3","key":"1817_CR17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","volume":"170","author":"A Bhattacharya","year":"2013","unstructured":"Bhattacharya A, Wang Q, Ao H, Shoblock JR, Lord B, Aluisio L, Fraser I, Nepomuceno D et al (2013) Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567. Br J Pharmacol 170(3):624\u2013640","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1817_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S1461145711001933","volume":"16","author":"C Cs\u00f6lle","year":"2013","unstructured":"Cs\u00f6lle C, And\u00f3 RD, Kittel \u00c1, G\u00f6l\u00f6ncs\u00e9r F, Baranyi M, Soproni K, Zelena D, Haller J et al (2013) The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice. Int J Neuropsychopharmacol 16(1):213\u2013233","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"1817_CR19","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1096\/fj.11-196089","volume":"26","author":"T Engel","year":"2012","unstructured":"Engel T, Gomez-Villafuertes R, Tanaka K, Mesuret G, Sanz-Rodriguez A, Garcia-Huerta P, Miras-Portugal MT, Henshall DC et al (2012) Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice. FASEB J 26(4):1616\u20131628","journal-title":"FASEB J"},{"issue":"5","key":"1817_CR20","first-page":"326","volume":"31","author":"BN Frey","year":"2006","unstructured":"Frey BN, Valvassori SS, R\u00e9us GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F et al (2006) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31(5):326\u2013332","journal-title":"J Psychiatry Neurosci"},{"issue":"1-2","key":"1817_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneumeth.2004.03.021","volume":"138","author":"ME Hows","year":"2004","unstructured":"Hows ME, Lacroix L, Heidbreder C, Organ AJ, Shah AJ (2004) High-performance liquid chromatography\/tandem mass spectrometric assay for the simultaneous measurement of dopamine, norepinephrine, 5-hydroxytryptamine and cocaine in biological samples. J Neurosci Methods 138(1-2):123\u2013132","journal-title":"J Neurosci Methods"},{"key":"1817_CR22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9673(01)91386-X","volume":"199","author":"W Voelter","year":"1980","unstructured":"Voelter W, Zech K, Arnold P, Ludwig G (1980) Determination of selected pyrimidines, purines and their metabolites in serum and urine by reversed-phase ion-pair chromatography. J Chromatogr 199:345\u2013354","journal-title":"J Chromatogr"},{"key":"1817_CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2010.05.064","volume":"1346","author":"CR Li","year":"2010","unstructured":"Li CR, Huang GB, Sui ZY, Han EH, Chung YC (2010) Effects of 6-hydroxydopamine lesioning of the medial prefrontal cortex on social interactions in adolescent and adult rats. Brain Res 1346:183\u2013189","journal-title":"Brain Res"},{"issue":"7","key":"1817_CR24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1399-5618.2012.01046.x","volume":"14","author":"DS Mac\u00eado","year":"2012","unstructured":"Mac\u00eado DS, Medeiros CD, Cordeiro RC, Sousa FC, Santos JV, Morais TA, Hyphantis TN, McIntyre R et al (2012) Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine. Bipolar Disord 14(7):707\u2013718","journal-title":"Bipolar Disord"},{"issue":"7","key":"1817_CR25","doi-asserted-by":"crossref","first-page":"e41229","DOI":"10.1371\/journal.pone.0041229","volume":"7","author":"DE Kimbler","year":"2012","unstructured":"Kimbler DE, Shields J, Yanasak N, Vender JR, Dhandapani KM (2012) Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice. PLoS One 7(7):e41229","journal-title":"PLoS One"},{"issue":"5","key":"1817_CR26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bjp.0707265","volume":"151","author":"DL Donnelly-Roberts","year":"2007","unstructured":"Donnelly-Roberts DL, Jarvis MF (2007) Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br J Pharmacol 151(5):571\u2013579","journal-title":"Br J Pharmacol"},{"key":"1817_CR27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","volume":"434","author":"M Berk","year":"2007","unstructured":"Berk M et al (2007) Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 434:41\u201349","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"5","key":"1817_CR28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuropharm.2006.06.002","volume":"51","author":"D Peleg-Raibstein","year":"2006","unstructured":"Peleg-Raibstein D, Feldon J (2006) Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release. Neuropharmacology 51(5):947\u2013957","journal-title":"Neuropharmacology"},{"issue":"7","key":"1817_CR29","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1176\/appi.ajp.157.7.1108","volume":"157","author":"A Anand","year":"2000","unstructured":"Anand A, Verhoeff P, Seneca N, Zoghbi SS, Seibyl JP, Charney DS, Innis RB (2000) Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 157(7):1108\u20131114","journal-title":"Am J Psychiatry"},{"issue":"10","key":"1817_CR30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1017\/S1092852900010403","volume":"10","author":"A Kugaya","year":"2005","unstructured":"Kugaya A, Sanacora G (2005) Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 10(10):808\u2013819","journal-title":"CNS Spectr"},{"key":"1817_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2015.09.004","volume":"56","author":"BC Haarman","year":"2016","unstructured":"Haarman BC et al (2016) Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - a combined magnetic resonance imaging and positron emission tomography study. Brain Behav Immun 56:21\u201333","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1817_CR32","first-page":"22","volume":"6","author":"F L\u00f3pez-Mu\u00f1oz","year":"2014","unstructured":"L\u00f3pez-Mu\u00f1oz F et al (2014) Ecstasy (3,4-methylenedioxymethamphetamine, MDMA): pharmacological, clinical, and criminological aspects. Trastornos Adictivos 6(1):22","journal-title":"Trastornos Adictivos"},{"issue":"4-5","key":"1817_CR33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002100000309","volume":"362","author":"H Zimmermann","year":"2000","unstructured":"Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedeberg's Arch Pharmacol 362(4-5):299\u2013309","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1817_CR34","doi-asserted-by":"crossref","unstructured":"Adinolfi E, et al. (2017) The P2X7 receptor: a main player in inflammation. Biochem Pharmacol","DOI":"10.1016\/j.bcp.2017.12.021"},{"issue":"3-4","key":"1817_CR35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/biof.5520080318","volume":"8","author":"F Di Virgilio","year":"1998","unstructured":"Di Virgilio F (1998) ATP as a death factor. Biofactors 8(3-4):301\u2013303","journal-title":"Biofactors"},{"issue":"2","key":"1817_CR36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11302-012-9339-y","volume":"9","author":"L Bulavina","year":"2013","unstructured":"Bulavina L, Szulzewsky F, Rocha A, Krabbe G, Robson SC, Matyash V, Kettenmann H (2013) NTPDase1 activity attenuates microglial phagocytosis. Purinergic Signal 9(2):199\u2013205","journal-title":"Purinergic Signal"},{"issue":"2","key":"1817_CR37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","volume":"2","author":"SC Robson","year":"2006","unstructured":"Robson SC, S\u00e9vigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2(2):409\u2013430","journal-title":"Purinergic Signal"},{"issue":"3","key":"1817_CR38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","volume":"16","author":"C Cekic","year":"2016","unstructured":"Cekic C, Linden J (2016) Purinergic regulation of the immune system. Nat Rev Immunol 16(3):177\u2013192","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1817_CR39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.coph.2007.09.002","volume":"8","author":"D Boison","year":"2008","unstructured":"Boison D (2008) Adenosine as a neuromodulator in neurological diseases. Curr Opin Pharmacol 8(1):2\u20137","journal-title":"Curr Opin Pharmacol"},{"key":"1817_CR40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.psychres.2016.10.007","volume":"246","author":"C Gubert","year":"2016","unstructured":"Gubert C, Jacintho Moritz CE, Vasconcelos-Moreno MP, Quadros Dos Santos BTM, Sartori J, Fijtman A, Kauer-Sant'Anna M, Kapczinski F et al (2016) Peripheral adenosine levels in euthymic patients with bipolar disorder. Psychiatry Res 246:421\u2013426","journal-title":"Psychiatry Res"},{"issue":"5","key":"1817_CR41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JCP.0b013e318268391d","volume":"32","author":"R Machado-Vieira","year":"2012","unstructured":"Machado-Vieira R (2012) Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania. J Clin Psychopharmacol 32(5):735\u2013736","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"1817_CR42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/14737159.2017.1270757","volume":"17","author":"F Bartoli","year":"2017","unstructured":"Bartoli F, Carr\u00e0 G, Clerici M (2017) Update on bipolar disorder biomarker candidates: what about uric acid\/adenosine hypothesis? Expert Rev Mol Diagn 17(2):105\u2013106","journal-title":"Expert Rev Mol Diagn"},{"key":"1817_CR43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","volume":"213","author":"J Maiuolo","year":"2016","unstructured":"Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V (2016) Regulation of uric acid metabolism and excretion. Int J Cardiol 213:8\u201314","journal-title":"Int J Cardiol"},{"issue":"16","key":"1817_CR44","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1111\/bph.13197","volume":"172","author":"RA Morton","year":"2015","unstructured":"Morton RA, Baptista-Hon DT, Hales TG, Lovinger DM (2015) Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors. Br J Pharmacol 172(16):4066\u20134077","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1817_CR45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-6147(00)88963-4","volume":"16","author":"G Milligan","year":"1995","unstructured":"Milligan G, Bond RA, Lee M (1995) Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 16(1):10\u201313","journal-title":"Trends Pharmacol Sci"},{"key":"1817_CR46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnins.2015.00148","volume":"9","author":"RJ Rodrigues","year":"2015","unstructured":"Rodrigues RJ, Tom\u00e9 AR, Cunha RA (2015) ATP as a multi-target danger signal in the brain. Front Neurosci 9:148","journal-title":"Front Neurosci"},{"issue":"2","key":"1817_CR47","doi-asserted-by":"crossref","first-page":"e1010937","DOI":"10.1080\/23723556.2015.1010937","volume":"3","author":"F Di Virgilio","year":"2016","unstructured":"Di Virgilio F (2016) P2RX7: a receptor with a split personality in inflammation and cancer. Mol Cell Oncol 3(2):e1010937","journal-title":"Mol Cell Oncol"},{"issue":"12","key":"1817_CR48","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/j.bpj.2013.05.006","volume":"104","author":"A Khadra","year":"2013","unstructured":"Khadra A, Tomi\u0107 M, Yan Z, Zemkova H, Sherman A, Stojilkovic SS (2013) Dual gating mechanism and function of P2X7 receptor channels. Biophys J 104(12):2612\u20132621","journal-title":"Biophys J"},{"issue":"30","key":"1817_CR49","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1523\/JNEUROSCI.3104-16.2017","volume":"37","author":"MT Miras-Portugal","year":"2017","unstructured":"Miras-Portugal MT, Sebasti\u00e1n-Serrano \u00c1, de Diego Garc\u00eda L, D\u00edaz-Hern\u00e1ndez M (2017) Neuronal P2X7 receptor: involvement in neuronal physiology and pathology. J Neurosci 37(30):7063\u20137072","journal-title":"J Neurosci"},{"key":"1817_CR50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2013.12.071","volume":"565","author":"M Pekny","year":"2014","unstructured":"Pekny M, Wilhelmsson U, Pekna M (2014) The dual role of astrocyte activation and reactive gliosis. Neurosci Lett 565:30\u201338","journal-title":"Neurosci Lett"},{"issue":"2","key":"1817_CR51","doi-asserted-by":"crossref","first-page":"a020420","DOI":"10.1101\/cshperspect.a020420","volume":"7","author":"MV Sofroniew","year":"2014","unstructured":"Sofroniew MV (2014) Astrogliosis. Cold Spring Harb Perspect Biol 7(2):a020420","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"1817_CR52","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/14737175.2016.1171144","volume":"16","author":"L Peng","year":"2016","unstructured":"Peng L, Li B, Verkhratsky A (2016) Targeting astrocytes in bipolar disorder. Expert Rev Neurother 16(6):649\u2013657","journal-title":"Expert Rev Neurother"},{"key":"1817_CR53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuroscience.2015.08.041","volume":"321","author":"RW Logan","year":"2016","unstructured":"Logan RW, McClung CA (2016) Animal models of bipolar mania: the past, present and future. Neuroscience 321:163\u2013188","journal-title":"Neuroscience"},{"issue":"14","key":"1817_CR54","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jpsychires.2010.02.009","volume":"44","author":"SS Valvassori","year":"2010","unstructured":"Valvassori SS, Rezin GT, Ferreira CL, Moretti M, Gon\u00e7alves CL, Cardoso MR, Streck EL, Kapczinski F et al (2010) Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatr Res 44(14):903\u2013909","journal-title":"J Psychiatr Res"},{"issue":"7","key":"1817_CR55","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1460-9568.2008.06443.x","volume":"28","author":"S T\u00e9trault","year":"2008","unstructured":"T\u00e9trault S, Chever O, Sik A, Amzica F (2008) Opening of the blood-brain barrier during isoflurane anaesthesia. Eur J Neurosci 28(7):1330\u20131341","journal-title":"Eur J Neurosci"},{"issue":"1","key":"1817_CR56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ki.2013.43","volume":"84","author":"M Kim","year":"2013","unstructured":"Kim M, Ham A, Kim JY, Brown KM, D'Agati VD, Lee HT (2013) The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury. Kidney Int 84(1):90\u2013103","journal-title":"Kidney Int"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01817-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01817-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01817-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:25:18Z","timestamp":1605313518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01817-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1817"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01817-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental procedures reported in this manuscript were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and the Brazilian College of Animal Experimentation. The Animal Ethics Committee of the Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre, Brazil, approved this project under protocol number 15-0192.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}